Practical optimization algorithms and engineering applications /

Por Antoniou, Andreas., Lu, Wu-Sheng.
Publicado em 2007

(131)I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma

Por He, Qing, Lu, Wu-Sheng, Liu, Yang, Guan, Yong-Song, Kuang, An-Ren
Publicado em 2013

Hepatic adenylate energy charge levels in patients with hepatoma after hepatic artery embolization

Por Li, Li, Yan, Lu-Nan, Chen, Xiao-Li, Lu, Wu-Sheng, Xie, Xiao-Dong, Wu, Yan-Tao
Publicado no World J Gastroenterol (1998)

Prognosis Evaluation in Patients with Hepatocellular Carcinoma after Hepatectomy: Comparison of BCLC, TNM and Hangzhou Criteria Staging Systems

Por Liu, Chang, Duan, Li-gen, Lu, Wu-sheng, Yan, Lu-nan, Xiao, Guang-qin, Jiang, Li, Yang, Jian, Yang, Jia-yin
Publicado em 2014

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

Por Liu, Chang, Li, Lei, Lu, Wu-sheng, Du, Hua, Yan, Lu-nan, Wen, Tian-fu, Wei, Wu-ran, Jiang, Li, Xu, Ming-qing
Publicado no BMC Cancer (2018)

Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization

Por Liu, Chang, Jia, Bang-sheng, Zou, Bing-wen, Du, Hua, Yan, Lu-nan, Yang, Jia-yin, Jiang, Li, Wen, Tian-fu, Lu, Wu-sheng
Publicado no Medicine (Baltimore) (2017)

Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization

Por Liu, Chang, Li, Lei, Lu, Wu-sheng, Du, Hua, Yan, Lu-nan, Yang, Jia-yin, Wen, Tian-fu, Zeng, Guo-jun, Jiang, Li, Yang, Jian
Publicado no Sci Rep (2017)

Management of venous stenosis in living donor liver transplant recipients

Por Yang, Jie, Xu, Ming-Qing, Yan, Lu-Nan, Lu, Wu-Sheng, Li, Xiao, Shi, Zheng-Rong, Li, Bo, Wen, Tian-Fu, Wang, Wen-Tao, Yang, Jia-Ying
Publicado em 2009